Immunome president and CEO Clay Siegall explains why the weeks following JP Morgan are just as important as the conference itself.Pharmaceutical Executive: What trends did you see at this year’s JP Morgan Healthcare Conference?Clay Siegall: I’ve been going to this conference for 25 years. In some years, it’s very exciting. In other years, it’s down. […]
